Million Dollar Round Table (MDRT) is a membership a life insurance or financial adviser earns by hitting a sales production target in a calendar year, then paying annual dues to the US-based association. In Singapore the 2026 cycle (measured on 2025 production) takes roughly S$72,400 in first-year commission, or about S$217,200 in eligible premium, or about S$125,400 in qualifying income. The name dates to 1927, when selling US$1 million of life insurance in a year was the bar. Today's threshold is a fraction of that in real terms, and the figure is set per market by MDRT, not by Singapore's regulator. The plain reading: MDRT tells you an adviser sold a lot last year. It says nothing direct about whether the products they sold were right for the client, because the metric is production, not advice quality.
MDRT is a private trade association, founded in 1927, that recognises life insurance and financial services professionals who hit an annual production target. By its own description it draws members from more than 80 nations and territories and nearly 700 companies. To qualify, an adviser meets a sales benchmark in a calendar year, holds a valid licence, agrees to the association's code of ethics, and pays membership dues. Hit the bar again next year and you requalify; miss it and you drop off.
The metric that counts is production. MDRT gives three ways to qualify in any market: a commission figure, an eligible-premium figure, or a qualifying-income figure. An adviser only needs to clear one of the three. The income route exists so fee-based and salaried advisers can qualify without relying purely on commission, but for most tied agents in Singapore the commission line is the one that gets quoted.
Two things follow from this. First, MDRT is recognition of selling volume in a single year, not a permanent title and not a professional qualification like the ones the regulator requires to give advice. Second, because the bar is set per market and reviewed each year, the same three letters mean a different sales figure in Singapore than in Indonesia or the United States.
MDRT publishes a production requirement for each market and adjusts it yearly against currency and economic movements. For the 2026 membership year, which is tracked against production earned during 2025, the Singapore thresholds widely cited across the industry are below. An adviser qualifies by clearing any one line, not all three.
The commission figure is the one most agents target because it maps directly to what they earn. Note that the qualifying number is not the same as take-home pay: it is gross production credited under MDRT's rules, before the adviser's own costs, and the premium route counts policy premium rather than the adviser's income at all.
These figures move year to year. Before you treat any number here as gospel, the live requirement for the current cycle sits on MDRT's own member-requirements page, and the figure your adviser quotes should match it. If you are weighing what an adviser sells you, the related question is whether the policy fits your needs, not the size of the threshold they cleared.
| Level | First-year commission | Eligible premium | Qualifying income |
|---|---|---|---|
| MDRT (base) | ~S$72,400 | ~S$217,200 | ~S$125,400 |
| Court of the Table (3x) | ~S$217,200 | ~S$651,600 | ~S$376,200 |
| Top of the Table (6x) | ~S$434,400 | ~S$1,303,200 | ~S$752,400 |
The Singapore threshold is not fixed, and it has fallen in nominal terms over the past decade. Industry reporting puts the 2017 first-year commission requirement at about S$124,100. By the time MDRT published its 2023 Singapore goal chart, based on 2022 production, the annual commission bar had dropped to S$72,400 and it sits at the same level for the 2026 cycle based on 2025 production. So the qualifying number is around 42 percent lower than it was eight years ago, before you even account for inflation eating into the real value of that figure.
The shape of the change matters more than a single before-and-after. The drop happened mainly in the years to 2022, and the commission bar has held flat near S$72,400 since. It is not a smooth annual slide. MDRT resets each market's number against currency and economic movements, so a year of a strong Singapore dollar or soft conditions can push it either way. The longer trend, though, is down.
For a reader weighing an adviser's badge, the takeaway is simple. An MDRT membership earned in 2025 cleared a lower bar than the same membership in 2017 would have, and a multi-year run that spans the drop mixes harder and easier years. None of that makes the adviser worse. It just means the three letters are a moving target, so the figure behind them is worth checking against the cycle it was earned in rather than treated as a constant.
| Cycle (based on prior-year production) | First-year commission | Eligible premium | Qualifying income |
|---|---|---|---|
| 2017 | ~S$124,100 | not directly comparable | not directly comparable |
| 2023 (on 2022 production) | S$72,400 | S$217,200 | S$125,400 |
| 2026 (on 2025 production) | ~S$72,400 | ~S$217,200 | ~S$125,400 |
Base MDRT is the entry rung. Above it sit two higher tiers that use the same three-way qualification, just at multiples of the base. Court of the Table (COT) is three times the base requirement. Top of the Table (TOT) is six times. So a Singapore adviser who books around S$434,400 in first-year commission in a year clears TOT on the commission line; one who books around S$217,200 clears COT.
You will often see advisers add the qualifying year and a count, such as MDRT 2023 to 2026 or four-time COT qualifier. That count is the number of separate years they hit the bar, which is genuine information about consistency of sales volume over time. It still measures sales, not whether last year's recommendations were suitable.
TOT producers are rare and tend to be top agents at the large insurers. AIA, for example, reported a record 19,358 MDRT qualifiers across its markets in 2025 and has led the global multinational ranking for eleven straight years, which gives a sense of how many agents are chasing the same target across Asia.
The name is historical, not a current threshold. When MDRT formed in 1927 in the United States, qualifying meant selling US$1 million of life insurance face value in a year, a serious feat at the time. The dollar amount in the name was the original sales bar, not a measure of an adviser's wealth or fees.
Almost a century of inflation later, the real qualifying bar is far below US$1 million of premium. Singapore's base premium route sits near S$217,200 and the commission route near S$72,400. The 'million dollar' branding survives because it is recognisable, not because anyone is selling a literal million in premium to qualify at base level.
So when an adviser says they are an MDRT member, read it as: last year I hit my market's production target. It is a credible signal that they are an active, productive seller. It is not a statement that any given client was sold the right policy.
MDRT is a useful but narrow signal. It tells you the adviser sold enough last year to clear a defined target, sustained a book of clients, and stayed in good standing on dues and ethics. For someone shopping for an adviser, that filters out the inactive and the brand new. It does not tell you the products they sold were the cheapest, the most suitable, or even appropriate, because the qualifying number rewards production regardless of which products generated it.
The structure of the metric matters here. Products with higher first-year commission, such as some whole life plans, endowment policies and investment-linked policies, move an adviser toward the threshold faster than low-commission or no-commission options. That is not a claim of misconduct, it is a structural pull: a target measured in commission naturally favours commission-heavy products. A client buying term life insurance, which is cheap and pays modest commission, contributes far less to an adviser's MDRT number than the same client buying a whole-life plan.
This is why MDRT is best read alongside, not instead of, the things that actually govern advice in Singapore. Every adviser who can give you financial advice has to be a licensed or appointed representative whose status you can verify on the Monetary Authority of Singapore's Financial Institutions Directory and the Register of Representatives. The advice process itself is governed by suitability rules, not by any sales club. Treat MDRT as a productivity badge, then do your own checks on fit and cost.
Practical move when an adviser leads with MDRT: ask what you are actually being recommended and why. Compare a term-and-invest approach against an ILP, ask for the premium and the commission disclosure, and read the Integrated Shield Plan or policy illustration before signing. The badge starts the conversation; the numbers in your own plan end it. Our guide to insurance in Singapore walks through how to decide what cover you actually need first.
It is fair to give MDRT its due before knocking it. An adviser who clears the bar year after year has, at minimum, kept a book of paying clients active and renewing. High producers often run on referrals, and a referral-heavy practice usually points to clients who were happy enough to send friends and family. High producers also tend to serve wealthier clients with more complex needs, which can mean the adviser has handled larger and more involved cases than a brand-new agent ever would. So the badge is a reasonable proxy for experience and staying power.
The counterweight is the one the structure of the metric forces on you. Production is measured largely in commission, and commission is heaviest on participating whole life, endowment and investment-linked plans. An adviser can clear the bar by selling a lot of high-commission product to a smaller number of clients, or by selling suitable lower-commission cover to many. The badge looks the same either way. That is why MDRT cannot, on its own, tell you which kind of practice you are dealing with.
Hold both ideas at once. The badge is a credible sign of an active, experienced seller, and it is silent on whether the specific plan in front of you is the right one at the right price. Use it to screen out the inactive and the untested, then judge the actual recommendation on its own merits. The two questions that settle it are the ones the badge never answers: is this the cover I need, and is this a fair price for it.
Every MDRT member agrees to the association's code of ethics as a condition of joining. The code asks members to put the client's interest ahead of their own, to keep their professional knowledge current, to hold client information in confidence, to disclose the facts a client needs to make an informed decision, and to conduct themselves in a way that reflects well on the profession. On paper it reads like the suitability principles a good adviser should already follow.
The limit is enforcement. MDRT is a trade association, not a regulator. It can decline or revoke membership, but it does not investigate your individual sale, order redress, or fine an adviser the way the Monetary Authority of Singapore can act on a licensed representative. If an adviser mis-sells you a policy, the venue for that is MAS's framework and the firm's own complaints process, not the round table. So the ethics pledge is a statement of intent, useful context, not a consumer-protection backstop.
Read it as a signal that an adviser has signed up to a standard, then rely on the rules that actually have teeth. The disclosure you are legally owed, the free-look period that lets you cancel a new policy within the cooling-off window, and the suitability obligations that govern the recommendation all sit under Singapore's regime, not MDRT's. Those are the protections to lean on if something goes wrong.
The cleanest way to place MDRT is to set it beside the checks that genuinely govern advice in Singapore and see what each one covers. The badge sits at the top of the list for signalling sales activity and at the bottom for everything a buyer actually needs to confirm. The table below lines them up so you can see where the badge helps and where you still have to do the work yourself.
Run through the right-hand column before you sign anything, regardless of how many MDRT years an adviser quotes. The licence check takes a minute on MAS's directory. The policy illustration shows you the premium, the charges and, for participating and investment-linked plans, the projected versus guaranteed values. A quick term-and-invest versus ILP comparison tells you whether you are paying for protection, investment, or a bundle of both at a higher cost.
| Check | What it confirms | Who backs it |
|---|---|---|
| MDRT membership | Adviser hit a sales target last year and is active | MDRT (trade association) |
| MAS licence / representative status | Adviser is legally allowed to advise you | Monetary Authority of Singapore |
| Suitability and disclosure rules | The recommendation must fit your needs and be explained | MAS regulatory framework |
| Policy illustration | The premium, charges and guaranteed vs projected values | The insurer |
| Free-look period | You can cancel a new policy within the cooling-off window | Insurer / MAS rules |
The path is straightforward and the same each year. The adviser tracks production through the calendar year against their market's target, applies to MDRT once they clear one of the three lines, and pays the annual membership dues. They must hold a valid licence in their jurisdiction and agree to MDRT's code of ethics. Membership is for the following year and lapses if they do not requalify.
Because qualification resets every January, advisers commonly run hard at year-end to clear the bar, which is worth knowing if you feel pressure to sign before 31 December. A suitable policy is suitable in February too. There is no client benefit to rushing a long-term commitment to help an adviser hit an annual target.
From your side, none of this requires action. You do not pay MDRT and your policy terms do not change based on your adviser's status. The only thing to carry away is how to read the badge: a verified sign of sales volume, to be weighed against the suitability and cost of whatever you are being sold.
It means they sold enough last year to hit their market's production target and stayed in good standing on licence, dues and ethics. That is a real signal of activity and productivity, but it measures sales volume, not whether any specific recommendation was suitable or low-cost. Check the policy illustration and verify the adviser's licence separately.
For the 2026 membership year (tracked on 2025 production), the Singapore thresholds commonly cited are about S$72,400 in first-year commission, or about S$217,200 in eligible premium, or about S$125,400 in qualifying income. An adviser only needs to clear one of the three. MDRT reviews these figures every year, so confirm the current number on MDRT's own member-requirements page.
They are three tiers of the same production metric. Base MDRT is the entry target. Court of the Table (COT) is three times the base. Top of the Table (TOT) is six times the base. In Singapore that puts COT near S$217,200 and TOT near S$434,400 on the first-year commission line.
No. MDRT is a private US-based trade association. It is not Singapore's regulator and not a licensing body. To give financial advice here, an adviser must be a licensed or appointed representative, which you can verify on the Monetary Authority of Singapore's Financial Institutions Directory and Register of Representatives. MDRT sits on top of that as a voluntary sales recognition.
When MDRT formed in 1927, qualifying meant selling US$1 million of life insurance face value in a year. The name preserves that original bar. Inflation has since pushed the real qualifying threshold well below a literal million, so the figure today is far smaller, for example Singapore's base premium route near S$217,200.
No. You do not pay MDRT and membership does not change your premium or policy terms. The adviser pays their own annual dues. Your cost is driven by the product you buy and its commission and charges, which you should review in the illustration regardless of the adviser's status.
The metric creates a structural pull. Because qualification is measured largely in commission, products with higher first-year commission such as whole life, endowment and investment-linked policies move an adviser toward the target faster than low-commission options like term insurance. That is not proof of mis-selling, but it is a reason to ask why a particular product is being recommended and to compare alternatives.
Down, in nominal terms. Industry reporting puts the 2017 first-year commission requirement at about S$124,100. MDRT's own 2023 Singapore goal chart set it at S$72,400, and the 2026 cycle sits at roughly the same level, so the bar is about 42 percent lower than it was in 2017. Most of the fall happened by 2022, and the figure has held steady since. MDRT re-sets the number each year against currency and economic conditions, so it can move either way.
Every member agrees to MDRT's code of ethics, which asks them to put client interest first, disclose fully and keep client information confidential. But MDRT is a trade association, not a regulator. It cannot investigate a sale, order redress or fine an adviser. Mis-selling complaints in Singapore go to the Monetary Authority of Singapore and the firm, not the round table. Treat the ethics pledge as a statement of intent, then rely on MAS's suitability and disclosure rules and the policy free-look period for actual protection.
MDRT credits eligible first-year commission, premium or qualifying income earned during the production year. Per MDRT's rules, levelized commission can be reported as the present value of up to the first five years discounted at 10 percent a year, capped at 55 percent of first-year premium, and overrides, training allowances, bonuses and incentive trips do not count. The figure is gross production credited under MDRT's definitions, not the adviser's take-home pay.
This is general financial information for Singapore, not personal financial advice. Figures change — verify current rates against the official sources above before acting. See our full disclaimer.